Centrus Energy Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw strong revenue growth, record backlog, and major contract wins in both LEU and HALEU markets. Guidance was reaffirmed, with workforce expansion and first centrifuge completion on track for 2026. Tight supply and robust demand continue to drive favorable pricing and order momentum.
-
The meeting covered director elections, executive compensation, and key governance proposals. All items except the officer exculpation amendment passed. Shareholder engagement and procedural transparency were emphasized, with no proposal-related questions received.
-
Q1 2026 saw strong operational progress, a $900M HALEU award, and raised revenue guidance to $450–$500M. Segment results showed higher technical solutions revenue and improved gross margin, with $1.9B in cash supporting expansion and strategic partnerships.
Fiscal Year 2025
-
2025 saw record revenue, strong backlog growth, and a $900M HALEU award, positioning for domestic uranium enrichment and national security. 2026 guidance is flat, with major investments in capacity and workforce, and a focus on de-risking supply and execution.
-
Q3 2025 revenue rose 30% year-over-year to $74.9 million, with net income of $3.9 million and a $3.9 billion backlog. Major capital raises, new hiring, and strong market demand position the company for rapid expansion amid tight enrichment supply and rising SWU prices.
-
Q2 2025 saw strong gross margins and robust cash reserves despite lower revenue, with significant progress in HALEU production and a growing backlog. The company is well-positioned for future growth, pending DOE funding decisions and continued industry momentum.
-
Q1 2025 saw revenue and profitability surge year-over-year, driven by shipment timing and lower SWU costs. The company maintains a strong cash position, a robust backlog, and a fully domestic supply chain, while awaiting major DOE funding decisions and benefiting from bipartisan political support.
Fiscal Year 2024
-
Revenue grew 40% year-over-year to $442 million, with strong margin performance and a $3.7 billion backlog. Major DOE contract wins, a $60 million manufacturing investment, and $402.5 million in convertible notes position the company for growth amid rising uranium prices and U.S. policy shifts.
-
Q3 2024 saw $57.7M in revenue and a $5M net loss, with results in line with expectations amid normal contract timing variability. Major new DOE awards and $2B in customer commitments support future growth, while backlog reached $3.8B.
-
Q2 2024 saw strong revenue and net income growth, driven by robust LEU deliveries and improved segment performance. The company strengthened its balance sheet, reduced pension liabilities, and remains well-positioned for future growth amid supportive federal policy and industry demand.
-
Nuclear sector momentum is rising due to energy independence and carbon-free goals, with enrichment remaining a highly restricted, high-barrier segment. The company is uniquely positioned as the only U.S. HALEU producer, with strong growth prospects in advanced reactors and national security.